ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,052Medicare Part D Prescriptions Filled, Including Refills

Rank: 108 out of 680

$1.05M Total Retail Price of All Prescriptions

Rank: 71 out of 680

717 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 717 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

15% of this provider’s 717 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 12,360 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 432 361 1 3
LEVOTHYROXINE SODIUM 421 295 2 2
HYDROCODONE-ACETAMINOPHEN 384 312 S3 3 4
LISINOPRIL 383 336 4 5
FUROSEMIDE 371 313 5 6
METFORMIN HCL 366 287 6 8
WARFARIN SODIUM 342 311 7 20
DONEPEZIL HCL 299 275 8 27
CARVEDILOL 278 245 9 23
AMLODIPINE BESYLATE 247 216 10 1
GLIMEPIRIDE 236 208 11 29
OMEPRAZOLE 230 202 12 7
TRAMADOL HCL 225 168 13 18
SERTRALINE HCL 210 186 14 28
DIOVAN 197 159 15 31
NAMENDA 196 196 16 35
AMITRIPTYLINE HCL 194 180 R 17 47
METOPROLOL TARTRATE 192 172 18 12
AZITHROMYCIN 188 148 19 42
ATORVASTATIN CALCIUM 168 120 20 11
SYNTHROID 155 149 21 38
GABAPENTIN 152 108 22 15
ATENOLOL 143 138 23 19
DIOVAN HCT 137 125 24 55
ALLOPURINOL 134 115 25 33
PREDNISONE 131 115 26 50
TAMSULOSIN HCL 130 110 27 34
ESCITALOPRAM OXALATE 122 122 28 45
NEXIUM 115 89 29 16
SINGULAIR 110 81 30 91
QUETIAPINE FUMARATE 109 99 31 64
LOSARTAN POTASSIUM 109 93 31 21
NIFEDIPINE ER 102 101 33 75
CYMBALTA 101 75 34 46
POLYETHYLENE GLYCOL 3350 100 78 35 62
MECLIZINE HCL 99 96 36 103
HYDROCHLOROTHIAZIDE 94 75 37 9
CITALOPRAM HBR 93 78 38 22
FLUOXETINE HCL 89 61 39 74
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 86 39 37
ISOSORBIDE MONONITRATE ER 89 80 39 59
SPIRIVA 86 65 42 70
CRESTOR 86 57 42 25
AMLODIPINE BESYLATE-BENAZEPRIL 84 64 44 43
CIPROFLOXACIN HCL 83 69 45 57
ADVAIR DISKUS 81 53 46 53
DIGOXIN 80 80 47 58
PANTOPRAZOLE SODIUM 77 56 48 30
CLOTRIMAZOLE-BETAMETHASONE 75 60 49 138
METOPROLOL SUCCINATE 74 64 50 13
INSULIN SYRINGE 74 51 50 86
POTASSIUM CHLORIDE 74 61 50 14
TRICOR 73 51 53 98
VESICARE 70 43 54 176
NIASPAN 70 14 54 181
LANTUS 69 54 56 49
EXELON 67 66 57 112
ALENDRONATE SODIUM 67 54 57 32
PRAVASTATIN SODIUM 66 49 59 10
SPIRONOLACTONE 65 55 60 82
DOXAZOSIN MESYLATE 64 32 61 73
PEN NEEDLE 64 57 61 122
DILTIAZEM 24HR ER 64 64 61 132
CLOPIDOGREL 64 62 61 26
LANTUS SOLOSTAR 64 47 61 84
AGGRENOX 63 63 66 177
ZOLPIDEM TARTRATE 60 51 67 17
TRAZODONE HCL 59 50 68 48
JANUVIA 58 44 69 60
BENAZEPRIL HCL 58 42 69 40
ACTOS 57 39 71 114
EXFORGE 56 56 72 151
MONTELUKAST SODIUM 55 46 73 157
PREMARIN 55 55 R 73 105
MIRTAZAPINE 54 54 75 78
LIPITOR 53 37 76 68
RISPERIDONE 51 0 77 80
LEXAPRO 51 40 77 128
SEROQUEL XR 50 23 79 235
METFORMIN HCL ER 50 37 79 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.